Park Ha Biological Technology Co BYAH · USD
Consumer Discretionary · US listing · 🇺🇸 United States
2.18
+0.93%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Park Ha Biological Technology Co
Its shares trade under the ticker BYAH. It has been listed since 27 December 2024. In the fiscal year to 31 October 2024, it reported revenue of CN¥2.4m and net income of CN¥478,600. At that date it held total assets of CN¥3.1m and shareholders' equity of CN¥1.5m.
Park Ha Biological Technology Co Ltd is a CN-based company operating in Specialty Retail industry. The company is headquartered in Wuxi, Jiangsu. The company went IPO on 2024-12-27. Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in China market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Discretionary
- Industry
- Specialty Retail
- Listed since
- 27 Dec 2024
- Website
- ir.parkha.cn ↗
- Head office
- NO. 50 XIUXI ROAD, WUXI CITY, F4, 214135
- Incorporated in
- F4
- Classification
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Ms. Xiaoqiu ZhangChairman of the Board, Chief Executive Officer, since 2022
- Ms. Xiaoyan ZhuChief Financial Officer
- Ms. Xinyu LiChief Technology Officer, Product Manager
- Ms. Li WangDirector
- Ms. Yanan ShanIndependent Director Nominee
- Mr. Qixiong ShengIndependent Director
- Mr. Xiaozhong YuIndependent Director Nominee
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Park Ha Biological Technology Co Ltd operates in the Consumer Discretionary sector with a focus on Retail industry in China.
- The company's Products Sales segment offers skincare and cosmetic products under the brand name Park Ha in physical stores.
- The Franchise Service segment manages franchise agreements for stores under the brand names Park Ha and Geni.
Weaknesses
- The company's business is limited to the China market, with no mention of international expansion.
- The IPO date is scheduled for December 27, 2024, indicating a recent listing with limited historical market presence.
- The company operates through only two business segments: Products Sales and Franchise Service.
Opportunities
- The company can expand its product line beyond Little Blue Injection Serum and Parkha Amino Acid Cleansing Foam.
- The Franchise Service segment offers potential for growth through additional franchise agreements in China.
- The company's focus on skincare and cosmetic products aligns with the growing consumer demand in China's retail sector.
Threats
- The company's reliance on the China market exposes it to regional economic fluctuations.
- The upcoming IPO on December 27, 2024, may face market volatility affecting investor confidence.
- The company's limited product range, including only Little Blue Injection Serum and Parkha Amino Acid Cleansing Foam, may face competition from broader product offerings.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.